Imugene Limited
IUGNF
$0.1741
-$0.0073-4.02%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -15.75M | -16.19M | -26.68M | -26.62M | -22.39M |
| Total Depreciation and Amortization | 425.80K | 437.80K | 1.31M | 1.31M | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.74M | 2.82M | 7.51M | 7.49M | 6.61M |
| Change in Net Operating Assets | -- | -- | 1.10M | 1.10M | -- |
| Cash from Operations | -12.58M | -12.94M | -16.76M | -16.72M | -15.78M |
| Capital Expenditure | -3.51M | -3.61M | 213.60K | 213.20K | -2.52M |
| Sale of Property, Plant, and Equipment | -- | -- | 474.30K | 473.30K | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.06M | -3.14M | 1.52M | 1.51M | -2.83M |
| Cash from Investing | -6.56M | -6.75M | 2.20M | 2.20M | -5.34M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -219.50K | -219.50K | -696.30K | -696.30K | -73.40K |
| Issuance of Common Stock | 800.00 | 800.00 | 248.80K | 248.80K | 26.60M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 0.00 | -1.37M |
| Cash from Financing | -142.50K | -146.50K | -294.90K | -294.30K | 16.40M |
| Foreign Exchange rate Adjustments | -52.50K | -54.00K | -404.20K | -403.30K | 238.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.34M | -19.89M | -15.25M | -15.22M | -4.48M |